Advertisement

Index by author

December 01, 1990; Volume 255,Issue 3

A

  1. Adachi, O

    1. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
      Y Hamagishi, S Murata, H Kamei, T Oki, O Adachi and M Ameyama
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 980-985;

  2. Adams, J U

    1. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
      J U Adams, C A Paronis and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1027-1032;

  3. Aihara, H

    1. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
      Y Isobe, H Nagai, M Muramatsu, H Aihara and S Otomo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1078-1082;

  4. Ameyama, M

    1. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
      Y Hamagishi, S Murata, H Kamei, T Oki, O Adachi and M Ameyama
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 980-985;

  5. Anderson, J J

    1. Effect of local inhibition of gamma-aminobutyric acid uptake in the dorsomedial hypothalamus on extracellular levels of gamma-aminobutyric acid and on stress-induced tachycardia: a study using microdialysis.
      J J Anderson and J A DiMicco
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1399-1407;

  6. Antoine, M H

    1. Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells.
      P Lebrun, M H Antoine, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 948-954;

  7. Armstead, W M

    1. Prostanoids modulate opioid cerebrovascular responses in newborn pigs.
      W M Armstead, R Mirro, D W Busija and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1083-1089;

  8. Arnold, A J

    1. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
      S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming and S L Keely
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1021-1026;

  9. Arnold, R

    1. Pravadoline: profile in isolated tissue preparations.
      S J Ward, D Mastriani, F Casiano and R Arnold
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1230-1239;

  10. Asada, A

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  11. Axelrod, J

    1. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
      C C Felder, P Dieter, J Kinsella, K Tamura, R Y Kanterman and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1140-1147;

B

  1. Baimbridge, K G

    1. Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium.
      E Puil, H el-Beheiry and K G Baimbridge
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 955-961;

  2. Beckerman, R C

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  3. Bellan, J A

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  4. Bemis, K G

    1. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
      H E Shannon, K G Bemis, J C Hendrix and J S Ward
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1071-1077;

  5. Benet, L Z

    1. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
      F W Lee, T Salmonson, C H Metzler and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1222-1229;

  6. Berens, K

    1. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
      A Poling, J Cleary, K Berens and T Thompson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1240-1245;

  7. Berson, A

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;
    2. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
      B Fromenty, C Fisch, A Berson, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1377-1384;

  8. Beutler, J J

    1. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
      J J Beutler, H A Koomans, J A Bijlsma and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1314-1319;

  9. Bijlsma, J A

    1. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
      J J Beutler, H A Koomans, J A Bijlsma and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1314-1319;

  10. Black, C K

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  11. Bogert, C L

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

  12. Bolaños, F J

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  13. Bowyer, J F

    1. Effect of aging on alpha-1 adrenergic stimulation of phosphoinositide hydrolysis in various regions of rat brain.
      D M Burnett, J F Bowyer, J M Masserano and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1265-1270;

  14. Braquet, P

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  15. Brassard, C L

    1. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
      S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming and S L Keely
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1021-1026;

  16. Brimfield, A A

    1. Reversal of intracellular toxicity of the trichothecene mycotoxin T-2 with monoclonal antibody.
      K W Hunter, A A Brimfield, A T Knower, J A Powell and G Z Feuerstein
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1183-1187;

  17. Brodie, C

    1. Effects of ethanol on voltage-sensitive Na-channels in cultured skeletal muscle: up-regulation as a result of chronic treatment.
      C Brodie and S R Sampson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1195-1201;

  18. Burnett, D M

    1. Effect of aging on alpha-1 adrenergic stimulation of phosphoinositide hydrolysis in various regions of rat brain.
      D M Burnett, J F Bowyer, J M Masserano and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1265-1270;

  19. Busija, D W

    1. Prostanoids modulate opioid cerebrovascular responses in newborn pigs.
      W M Armstead, R Mirro, D W Busija and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1083-1089;

C

  1. Casals-Stenzel, J

    1. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
      H O Heuer, J Casals-Stenzel, G Muacevic and K H Weber
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 962-968;

  2. Casiano, F

    1. Pravadoline: profile in isolated tissue preparations.
      S J Ward, D Mastriani, F Casiano and R Arnold
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1230-1239;

  3. Castle, N A

    1. Bupivacaine inhibits the transient outward K+ current but not the inward rectifier in rat ventricular myocytes.
      N A Castle
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1038-1046;

  4. Cheng, H C

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  5. Ching, M S

    1. Ontogeny of fetal renal organic cation excretion: a study with cimetidine and ranitidine during the latter half of gestation in the pregnant ewe.
      M A Czuba, D J Morgan, M S Ching, G W Mihaly, K J Hardy and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1177-1182;

  6. Claro, E

    1. Comparison of serotoninergic to muscarinic cholinergic stimulation of phosphoinositide-specific phospholipase C in rat brain cortical membranes.
      M A Wallace and E Claro
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1296-1300;

  7. Cleary, J

    1. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
      A Poling, J Cleary, K Berens and T Thompson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1240-1245;

  8. Czuba, M A

    1. Ontogeny of fetal renal organic cation excretion: a study with cimetidine and ranitidine during the latter half of gestation in the pregnant ewe.
      M A Czuba, D J Morgan, M S Ching, G W Mihaly, K J Hardy and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1177-1182;

D

  1. Dage, R C

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  2. Daly, J W

    1. Stimulatory effects of maitotoxin on insulin release in insulinoma HIT cells: role of calcium uptake and phosphoinositide breakdown.
      D G Soergel, F Gusovsky, T Yasumoto and J W Daly
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1360-1365;

  3. Dar, M S

    1. Central adenosinergic system involvement in ethanol-induced motor incoordination in mice.
      M S Dar
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1202-1209;

  4. Defaux, J P

    1. Effect of selective sigma ligands on duodenal alkaline secretion in the rat.
      X Pascaud, J P Defaux, C Rozé and J L Junien
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1354-1359;

  5. Degott, C

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;

  6. Dempster, J

    1. End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.
      C Prior, J F Fiekers, F Henderson, J Dempster, I G Marshall and R L Parsons
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1170-1176;

  7. Deschamps, D

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;

  8. Devreux, V

    1. Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells.
      P Lebrun, M H Antoine, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 948-954;

  9. Dhalla, N S

    1. Cardiac sarcolemma as a possible site of action of caffeine in rat heart.
      M P Gupta, N Makino, S Takeo, M Kaneko and N S Dhalla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1188-1194;

  10. Dieter, P

    1. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
      C C Felder, P Dieter, J Kinsella, K Tamura, R Y Kanterman and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1140-1147;

  11. DiMicco, J A

    1. Effect of local inhibition of gamma-aminobutyric acid uptake in the dorsomedial hypothalamus on extracellular levels of gamma-aminobutyric acid and on stress-induced tachycardia: a study using microdialysis.
      J J Anderson and J A DiMicco
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1399-1407;

  12. Dorhout Mees, E J

    1. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
      J J Beutler, H A Koomans, J A Bijlsma and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1314-1319;

  13. Dourish, C T

    1. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
      C T Dourish, M F O'Neill, L W Schaffer, P K Siegl and S D Iversen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1158-1165;

  14. Dubuc, P U

    1. Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice.
      P U Dubuc and C M Peterson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 976-979;

  15. Dunn, A J

    1. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
      X M Yang, A L Gorman and A J Dunn
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1064-1070;

  16. Dyson, M C

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

E

  1. Ehlert, F J

    1. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
      F J Ehlert and L P Tran
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1148-1157;

  2. Eikenburg, D C

    1. Effects of chronic norepinephrine administration on sympathetic neurotransmission in the isolated perfused rat kidney.
      D C Eikenburg
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1053-1059;

  3. el-Beheiry, H

    1. Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium.
      E Puil, H el-Beheiry and K G Baimbridge
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 955-961;

  4. Ellinwood, E H

    1. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics.
      E H Ellinwood, A M Nikaido, S K Gupta, D G Heatherly and J K Nishita
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1133-1139;

  5. Enomoto, K

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  6. Evans, S M

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;
    2. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
      S M Evans, F R Funderburk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1246-1255;

F

  1. Fang, S N

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

  2. Fasehun, O A

    1. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
      O A Fasehun, S S Gross, L E Rubin, E A Jaffe, O W Griffith and R Levi
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1348-1353;

  3. Fattaccini, C M

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  4. Felder, C C

    1. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
      C C Felder, P Dieter, J Kinsella, K Tamura, R Y Kanterman and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1140-1147;

  5. Fernandes, M H

    1. Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney.
      M H Fernandes and P Soares-da-Silva
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1309-1313;

  6. Ferrario, C M

    1. Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists.
      G J Trachte, C M Ferrario and M C Khosla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 929-934;

  7. Feuerstein, G Z

    1. Reversal of intracellular toxicity of the trichothecene mycotoxin T-2 with monoclonal antibody.
      K W Hunter, A A Brimfield, A T Knower, J A Powell and G Z Feuerstein
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1183-1187;

  8. Fiekers, J F

    1. End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.
      C Prior, J F Fiekers, F Henderson, J Dempster, I G Marshall and R L Parsons
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1170-1176;

  9. Fisch, C

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;
    2. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
      B Fromenty, C Fisch, A Berson, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1377-1384;

  10. Fleming, J S

    1. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
      S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming and S L Keely
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1021-1026;

  11. France, C P

    1. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
      C P France, Y Lu and J H Woods
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1271-1277;

  12. Fromenty, B

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;
    2. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
      B Fromenty, C Fisch, A Berson, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1377-1384;

  13. Fujimori, M

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  14. Fujita, S

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  15. Funae, Y

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  16. Funderburk, F R

    1. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
      S M Evans, F R Funderburk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1246-1255;

  17. Fung, H L

    1. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
      E A Kowaluk and H L Fung
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1256-1264;

G

  1. Gay, R G

    1. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
      T E Raya, R G Gay and S Goldman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1015-1020;

  2. Goldman, S

    1. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
      T E Raya, R G Gay and S Goldman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1015-1020;

  3. Gorman, A L

    1. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
      X M Yang, A L Gorman and A J Dunn
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1064-1070;

  4. Gozlan, H

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  5. Griffith, O W

    1. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
      O A Fasehun, S S Gross, L E Rubin, E A Jaffe, O W Griffith and R Levi
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1348-1353;

  6. Griffith, W H

    1. Comparison of 4-aminopyridine and tetrahydroaminoacridine on basal forebrain neurons.
      W H Griffith and J A Sim
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 986-993;

  7. Griffiths, R R

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;
    2. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
      S M Evans, F R Funderburk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1246-1255;

  8. Gross, S S

    1. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
      O A Fasehun, S S Gross, L E Rubin, E A Jaffe, O W Griffith and R Levi
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1348-1353;

  9. Guengerich, F P

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  10. Gupta, M P

    1. Cardiac sarcolemma as a possible site of action of caffeine in rat heart.
      M P Gupta, N Makino, S Takeo, M Kaneko and N S Dhalla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1188-1194;

  11. Gupta, S K

    1. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics.
      E H Ellinwood, A M Nikaido, S K Gupta, D G Heatherly and J K Nishita
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1133-1139;

  12. Gusovsky, F

    1. Stimulatory effects of maitotoxin on insulin release in insulinoma HIT cells: role of calcium uptake and phosphoinositide breakdown.
      D G Soergel, F Gusovsky, T Yasumoto and J W Daly
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1360-1365;

H

  1. Haj-Dahmane, S

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  2. Hamagishi, Y

    1. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
      Y Hamagishi, S Murata, H Kamei, T Oki, O Adachi and M Ameyama
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 980-985;

  3. Hamon, M

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  4. Hardy, K J

    1. Ontogeny of fetal renal organic cation excretion: a study with cimetidine and ranitidine during the latter half of gestation in the pregnant ewe.
      M A Czuba, D J Morgan, M S Ching, G W Mihaly, K J Hardy and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1177-1182;

  5. Harris, S

    1. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
      M H Ossipov, S Harris, P Lloyd and E Messineo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1107-1116;

  6. Hayashi, Y

    1. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
      T Kanayama, Y Kimura, K Iseki, Y Hayashi, Y Tamao and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1210-1217;

  7. Heatherly, D G

    1. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics.
      E H Ellinwood, A M Nikaido, S K Gupta, D G Heatherly and J K Nishita
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1133-1139;

  8. Heishman, S J

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;

  9. Henderson, F

    1. End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.
      C Prior, J F Fiekers, F Henderson, J Dempster, I G Marshall and R L Parsons
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1170-1176;

  10. Hendrix, J C

    1. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
      H E Shannon, K G Bemis, J C Hendrix and J S Ward
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1071-1077;

  11. Herchuelz, A

    1. Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells.
      P Lebrun, M H Antoine, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 948-954;

  12. Hermann, M

    1. Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells.
      P Lebrun, M H Antoine, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 948-954;

  13. Heuer, H O

    1. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
      H O Heuer, J Casals-Stenzel, G Muacevic and K H Weber
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 962-968;

  14. Holtzman, S G

    1. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
      J U Adams, C A Paronis and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1027-1032;

  15. Hori, R

    1. Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.
      T Okano, H Maegawa, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1033-1037;

  16. Howell, R E

    1. Multiple mechanisms of xanthine actions on airway reactivity.
      R E Howell
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1008-1014;

  17. Hruby, V J

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

  18. Hunter, K W

    1. Reversal of intracellular toxicity of the trichothecene mycotoxin T-2 with monoclonal antibody.
      K W Hunter, A A Brimfield, A T Knower, J A Powell and G Z Feuerstein
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1183-1187;

I

  1. Ignar, D M

    1. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
      D M Ignar and C M Kuhn
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1287-1295;

  2. Imaoka, S

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  3. Inui, K

    1. Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.
      T Okano, H Maegawa, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1033-1037;

  4. Iseki, K

    1. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
      T Kanayama, Y Kimura, K Iseki, Y Hayashi, Y Tamao and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1210-1217;

  5. Isobe, Y

    1. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
      Y Isobe, H Nagai, M Muramatsu, H Aihara and S Otomo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1078-1082;

  6. Itoh, Y

    1. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1090-1097;

  7. Iuvone, P M

    1. Alpha-2 adrenergic activity of bromocriptine and quinpirole in chicken pineal gland. Effects on melatonin synthesis and [3H]rauwolscine binding.
      J Zawilska and P M Iuvone
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1047-1052;

  8. Iversen, S D

    1. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
      C T Dourish, M F O'Neill, L W Schaffer, P K Siegl and S D Iversen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1158-1165;

J

  1. Jaeschke, H

    1. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol.
      H Jaeschke
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 935-941;

  2. Jaffe, E A

    1. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
      O A Fasehun, S S Gross, L E Rubin, E A Jaffe, O W Griffith and R Levi
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1348-1353;

  3. Johnson, K M

    1. Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
      A I Sacaan and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1060-1063;

  4. Jones, L F

    1. Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery and the femoral artery to vasoactive substances.
      L F Jones and R L Tackett
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1366-1370;

  5. Jones, W D

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  6. Junien, J L

    1. Effect of selective sigma ligands on duodenal alkaline secretion in the rat.
      X Pascaud, J P Defaux, C Rozé and J L Junien
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1354-1359;

K

  1. Kadowitz, P J

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  2. Kalabis, G M

    1. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
      G M Kalabis and P G Wells
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1408-1419;

  3. Kamei, H

    1. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
      Y Hamagishi, S Murata, H Kamei, T Oki, O Adachi and M Ameyama
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 980-985;

  4. Kanayama, T

    1. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
      T Kanayama, Y Kimura, K Iseki, Y Hayashi, Y Tamao and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1210-1217;

  5. Kaneko, M

    1. Cardiac sarcolemma as a possible site of action of caffeine in rat heart.
      M P Gupta, N Makino, S Takeo, M Kaneko and N S Dhalla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1188-1194;

  6. Kanterman, R Y

    1. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
      C C Felder, P Dieter, J Kinsella, K Tamura, R Y Kanterman and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1140-1147;

  7. Kariya, T

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  8. Katusic, Z S

    1. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
      V B Schini, Z S Katusic and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 994-1000;

  9. Keely, S L

    1. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
      S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming and S L Keely
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1021-1026;

  10. Khosla, M C

    1. Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists.
      G J Trachte, C M Ferrario and M C Khosla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 929-934;

  11. Kimura, Y

    1. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
      T Kanayama, Y Kimura, K Iseki, Y Hayashi, Y Tamao and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1210-1217;

  12. Kinsella, J

    1. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
      C C Felder, P Dieter, J Kinsella, K Tamura, R Y Kanterman and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1140-1147;

  13. Knapp, R J

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

  14. Knower, A T

    1. Reversal of intracellular toxicity of the trichothecene mycotoxin T-2 with monoclonal antibody.
      K W Hunter, A A Brimfield, A T Knower, J A Powell and G Z Feuerstein
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1183-1187;

  15. Kobayashi, E

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

  16. Koomans, H A

    1. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
      J J Beutler, H A Koomans, J A Bijlsma and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1314-1319;

  17. Kowaluk, E A

    1. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
      E A Kowaluk and H L Fung
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1256-1264;

  18. Kuhn, C M

    1. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
      D M Ignar and C M Kuhn
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1287-1295;

L

  1. Labbe, G

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;

  2. Lanfumey, L

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  3. Laporte, A M

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  4. Larrey, D

    1. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
      B Fromenty, C Fisch, A Berson, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1377-1384;

  5. Leander, J D

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;

  6. Lebrun, P

    1. Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells.
      P Lebrun, M H Antoine, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 948-954;

  7. Lee, F W

    1. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
      F W Lee, T Salmonson, C H Metzler and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1222-1229;

  8. Leffler, C W

    1. Prostanoids modulate opioid cerebrovascular responses in newborn pigs.
      W M Armstead, R Mirro, D W Busija and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1083-1089;

  9. Letteron, P

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;
    2. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
      B Fromenty, C Fisch, A Berson, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1377-1384;

  10. Levi, R

    1. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
      O A Fasehun, S S Gross, L E Rubin, E A Jaffe, O W Griffith and R Levi
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1348-1353;

  11. Leysen, J E

    1. Neurotoxic action of veratridine in rat brain neuronal cultures: mechanism of neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels.
      P J Pauwels, H P Van Assouw, L Peeters and J E Leysen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1117-1122;

  12. Lloyd, P

    1. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
      M H Ossipov, S Harris, P Lloyd and E Messineo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1107-1116;

  13. Lodge, D

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;

  14. Lu, Y

    1. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
      C P France, Y Lu and J H Woods
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1271-1277;

M

  1. Maegawa, H

    1. Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.
      T Okano, H Maegawa, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1033-1037;

  2. Makino, N

    1. Cardiac sarcolemma as a possible site of action of caffeine in rat heart.
      M P Gupta, N Makino, S Takeo, M Kaneko and N S Dhalla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1188-1194;

  3. Marshall, I G

    1. End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.
      C Prior, J F Fiekers, F Henderson, J Dempster, I G Marshall and R L Parsons
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1170-1176;

  4. Masserano, J M

    1. Effect of aging on alpha-1 adrenergic stimulation of phosphoinositide hydrolysis in various regions of rat brain.
      D M Burnett, J F Bowyer, J M Masserano and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1265-1270;

  5. Mastriani, D

    1. Pravadoline: profile in isolated tissue preparations.
      S J Ward, D Mastriani, F Casiano and R Arnold
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1230-1239;

  6. McNamara, D B

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  7. Meanwell, N A

    1. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
      S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming and S L Keely
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1021-1026;

  8. Messineo, E

    1. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
      M H Ossipov, S Harris, P Lloyd and E Messineo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1107-1116;

  9. Metzler, C H

    1. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
      F W Lee, T Salmonson, C H Metzler and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1222-1229;

  10. Mihaly, G W

    1. Ontogeny of fetal renal organic cation excretion: a study with cimetidine and ranitidine during the latter half of gestation in the pregnant ewe.
      M A Czuba, D J Morgan, M S Ching, G W Mihaly, K J Hardy and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1177-1182;

  11. Minkes, R K

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  12. Mironneau, C

    1. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
      L Rakotoarisoa, I Sayet, C Mironneau and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 942-947;

  13. Mironneau, J

    1. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
      L Rakotoarisoa, I Sayet, C Mironneau and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 942-947;

  14. Mirro, R

    1. Prostanoids modulate opioid cerebrovascular responses in newborn pigs.
      W M Armstead, R Mirro, D W Busija and C W Leffler
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1083-1089;

  15. Mizogami, S

    1. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
      T Kanayama, Y Kimura, K Iseki, Y Hayashi, Y Tamao and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1210-1217;

  16. Morgan, D J

    1. Ontogeny of fetal renal organic cation excretion: a study with cimetidine and ranitidine during the latter half of gestation in the pregnant ewe.
      M A Czuba, D J Morgan, M S Ching, G W Mihaly, K J Hardy and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1177-1182;

  17. Morse, W H

    1. Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
      J G Wettstein, E S Teeple and W H Morse
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1328-1334;

  18. Muacevic, G

    1. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
      H O Heuer, J Casals-Stenzel, G Muacevic and K H Weber
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 962-968;

  19. Murakata, C

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

  20. Muramatsu, M

    1. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
      Y Isobe, H Nagai, M Muramatsu, H Aihara and S Otomo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1078-1082;

  21. Murata, S

    1. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
      Y Hamagishi, S Murata, H Kamei, T Oki, O Adachi and M Ameyama
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 980-985;

N

  1. Nagai, H

    1. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
      Y Isobe, H Nagai, M Muramatsu, H Aihara and S Otomo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1078-1082;

  2. Nakano, H

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

  3. Nichols, D E

    1. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
      R Oberlender and D E Nichols
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1098-1106;

  4. Nikaido, A M

    1. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics.
      E H Ellinwood, A M Nikaido, S K Gupta, D G Heatherly and J K Nishita
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1133-1139;

  5. Nishibori, M

    1. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1090-1097;

  6. Nishita, J K

    1. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics.
      E H Ellinwood, A M Nikaido, S K Gupta, D G Heatherly and J K Nishita
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1133-1139;

O

  1. O'Neill, M F

    1. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
      C T Dourish, M F O'Neill, L W Schaffer, P K Siegl and S D Iversen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1158-1165;

  2. Oberlender, R

    1. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
      R Oberlender and D E Nichols
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1098-1106;

  3. Oda, Y

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  4. Oishi, R

    1. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1090-1097;

  5. Okano, T

    1. Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.
      T Okano, H Maegawa, K Inui and R Hori
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1033-1037;

  6. Oki, T

    1. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
      Y Hamagishi, S Murata, H Kamei, T Oki, O Adachi and M Ameyama
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 980-985;

  7. Opgenorth, T J

    1. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure.
      D M Pollock and T J Opgenorth
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1166-1169;

  8. Ornstein, P L

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;

  9. Ossipov, M H

    1. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
      M H Ossipov, S Harris, P Lloyd and E Messineo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1107-1116;

  10. Otomo, S

    1. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
      Y Isobe, H Nagai, M Muramatsu, H Aihara and S Otomo
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1078-1082;

P

  1. Paronis, C A

    1. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
      J U Adams, C A Paronis and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1027-1032;

  2. Parsons, R L

    1. End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.
      C Prior, J F Fiekers, F Henderson, J Dempster, I G Marshall and R L Parsons
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1170-1176;

  3. Pascaud, X

    1. Effect of selective sigma ligands on duodenal alkaline secretion in the rat.
      X Pascaud, J P Defaux, C Rozé and J L Junien
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1354-1359;

  4. Pauwels, P J

    1. Neurotoxic action of veratridine in rat brain neuronal cultures: mechanism of neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels.
      P J Pauwels, H P Van Assouw, L Peeters and J E Leysen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1117-1122;

  5. Peeters, L

    1. Neurotoxic action of veratridine in rat brain neuronal cultures: mechanism of neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels.
      P J Pauwels, H P Van Assouw, L Peeters and J E Leysen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1117-1122;

  6. Pessayre, D

    1. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      B Fromenty, C Fisch, G Labbe, C Degott, D Deschamps, A Berson, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1371-1376;
    2. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II.
      B Fromenty, C Fisch, A Berson, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1377-1384;

  7. Peterson, C M

    1. Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice.
      P U Dubuc and C M Peterson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 976-979;

  8. Poling, A

    1. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
      A Poling, J Cleary, K Berens and T Thompson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1240-1245;

  9. Pollock, D M

    1. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure.
      D M Pollock and T J Opgenorth
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1166-1169;

  10. Powell, J A

    1. Reversal of intracellular toxicity of the trichothecene mycotoxin T-2 with monoclonal antibody.
      K W Hunter, A A Brimfield, A T Knower, J A Powell and G Z Feuerstein
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1183-1187;

  11. Preston, K L

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;

  12. Prior, C

    1. End-plate ion channel block produced by lincosamide antibiotics and their chemical analogs.
      C Prior, J F Fiekers, F Henderson, J Dempster, I G Marshall and R L Parsons
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1170-1176;

  13. Pritchard, J B

    1. Rat renal cortical slices demonstrate p-aminohippurate/glutarate exchange and sodium/glutarate coupled p-aminohippurate transport.
      J B Pritchard
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 969-975;

  14. Puil, E

    1. Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium.
      E Puil, H el-Beheiry and K G Baimbridge
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 955-961;

R

  1. Rakotoarisoa, L

    1. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
      L Rakotoarisoa, I Sayet, C Mironneau and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 942-947;

  2. Raya, T E

    1. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
      T E Raya, R G Gay and S Goldman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1015-1020;

  3. Reynolds, I J

    1. Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor.
      I J Reynolds
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1001-1007;

  4. Robinson, P J

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  5. Rozé, C

    1. Effect of selective sigma ligands on duodenal alkaline secretion in the rat.
      X Pascaud, J P Defaux, C Rozé and J L Junien
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1354-1359;

  6. Rubin, L E

    1. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
      O A Fasehun, S S Gross, L E Rubin, E A Jaffe, O W Griffith and R Levi
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1348-1353;

S

  1. Sacaan, A I

    1. Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
      A I Sacaan and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1060-1063;

  2. Saeki, K

    1. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1090-1097;

  3. Saitoh, H

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

  4. Salhoff, C R

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;

  5. Salmonson, T

    1. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
      F W Lee, T Salmonson, C H Metzler and L Z Benet
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1222-1229;

  6. Sampson, S R

    1. Effects of ethanol on voltage-sensitive Na-channels in cultured skeletal muscle: up-regulation as a result of chronic treatment.
      C Brodie and S R Sampson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1195-1201;

  7. Sannerud, C A

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;

  8. Sayet, I

    1. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
      L Rakotoarisoa, I Sayet, C Mironneau and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 942-947;

  9. Schaffer, L W

    1. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
      C T Dourish, M F O'Neill, L W Schaffer, P K Siegl and S D Iversen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1158-1165;

  10. Schechter, L E

    1. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
      L E Schechter, F J Bolaños, H Gozlan, L Lanfumey, S Haj-Dahmane, A M Laporte, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1335-1347;

  11. Schini, V B

    1. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
      V B Schini, Z S Katusic and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 994-1000;

  12. Schmidt, C J

    1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle.
      P J Robinson, H C Cheng, C K Black, C J Schmidt, T Kariya, W D Jones and R C Dage
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1392-1398;

  13. Schoepp, D D

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;

  14. Seiler, S

    1. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
      S Seiler, C L Brassard, A J Arnold, N A Meanwell, J S Fleming and S L Keely
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1021-1026;

  15. Shannon, H E

    1. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
      H E Shannon, K G Bemis, J C Hendrix and J S Ward
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1071-1077;

  16. Shimada, T

    1. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
      S Imaoka, K Enomoto, Y Oda, A Asada, M Fujimori, T Shimada, S Fujita, F P Guengerich and Y Funae
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1385-1391;

  17. Siegl, P K

    1. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
      C T Dourish, M F O'Neill, L W Schaffer, P K Siegl and S D Iversen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1158-1165;

  18. Sim, J A

    1. Comparison of 4-aminopyridine and tetrahydroaminoacridine on basal forebrain neurons.
      W H Griffith and J A Sim
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 986-993;

  19. Smallwood, R A

    1. Ontogeny of fetal renal organic cation excretion: a study with cimetidine and ranitidine during the latter half of gestation in the pregnant ewe.
      M A Czuba, D J Morgan, M S Ching, G W Mihaly, K J Hardy and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1177-1182;

  20. Soares-da-Silva, P

    1. Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney.
      M H Fernandes and P Soares-da-Silva
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1309-1313;

  21. Soergel, D G

    1. Stimulatory effects of maitotoxin on insulin release in insulinoma HIT cells: role of calcium uptake and phosphoinositide breakdown.
      D G Soergel, F Gusovsky, T Yasumoto and J W Daly
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1360-1365;

  22. Suzuki, K

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

T

  1. Tackett, R L

    1. Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery and the femoral artery to vasoactive substances.
      L F Jones and R L Tackett
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1366-1370;

  2. Takahashi, I

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

  3. Takeo, S

    1. Cardiac sarcolemma as a possible site of action of caffeine in rat heart.
      M P Gupta, N Makino, S Takeo, M Kaneko and N S Dhalla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1188-1194;

  4. Tamao, Y

    1. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
      T Kanayama, Y Kimura, K Iseki, Y Hayashi, Y Tamao and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1210-1217;

  5. Tamaoki, T

    1. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C.
      I Takahashi, E Kobayashi, H Nakano, C Murakata, H Saitoh, K Suzuki and T Tamaoki
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1218-1221;

  6. Tamura, K

    1. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
      C C Felder, P Dieter, J Kinsella, K Tamura, R Y Kanterman and J Axelrod
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1140-1147;

  7. Teeple, E S

    1. Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
      J G Wettstein, E S Teeple and W H Morse
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1328-1334;

  8. Thompson, T

    1. Neuroleptics and learning: effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure.
      A Poling, J Cleary, K Berens and T Thompson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1240-1245;

  9. Trachte, G J

    1. Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists.
      G J Trachte, C M Ferrario and M C Khosla
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 929-934;

  10. Tran, L P

    1. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
      F J Ehlert and L P Tran
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1148-1157;

V

  1. Van Assouw, H P

    1. Neurotoxic action of veratridine in rat brain neuronal cultures: mechanism of neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels.
      P J Pauwels, H P Van Assouw, L Peeters and J E Leysen
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1117-1122;

  2. Vanhoutte, P M

    1. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
      V B Schini, Z S Katusic and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 994-1000;

  3. Vaughn, L K

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

W

  1. Wallace, M A

    1. Comparison of serotoninergic to muscarinic cholinergic stimulation of phosphoinositide-specific phospholipase C in rat brain cortical membranes.
      M A Wallace and E Claro
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1296-1300;

  2. Ward, J S

    1. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
      H E Shannon, K G Bemis, J C Hendrix and J S Ward
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1071-1077;

  3. Ward, S J

    1. Pravadoline: profile in isolated tissue preparations.
      S J Ward, D Mastriani, F Casiano and R Arnold
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1230-1239;

  4. Weber, K H

    1. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
      H O Heuer, J Casals-Stenzel, G Muacevic and K H Weber
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 962-968;

  5. Wegmann, M J

    1. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
      M C Dyson, J A Bellan, R K Minkes, R C Beckerman, M J Wegmann, P Braquet, D B McNamara and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1320-1327;

  6. Wells, P G

    1. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
      G M Kalabis and P G Wells
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1408-1419;

  7. Wettstein, J G

    1. Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
      J G Wettstein, E S Teeple and W H Morse
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1328-1334;

  8. Wolf, B

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;

  9. Woods, J H

    1. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
      C P France, Y Lu and J H Woods
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1271-1277;

  10. Woodson, P P

    1. Low-dose caffeine physical dependence in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1123-1132;

Y

  1. Yamamura, H I

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

  2. Yamamura, M S

    1. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
      R J Knapp, L K Vaughn, S N Fang, C L Bogert, M S Yamamura, V J Hruby and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1278-1286;

  3. Yang, X M

    1. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
      X M Yang, A L Gorman and A J Dunn
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1064-1070;

  4. Yasumoto, T

    1. Stimulatory effects of maitotoxin on insulin release in insulinoma HIT cells: role of calcium uptake and phosphoinositide breakdown.
      D G Soergel, F Gusovsky, T Yasumoto and J W Daly
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1360-1365;

Z

  1. Zahniser, N R

    1. Effect of aging on alpha-1 adrenergic stimulation of phosphoinositide hydrolysis in various regions of rat brain.
      D M Burnett, J F Bowyer, J M Masserano and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1265-1270;

  2. Zawilska, J

    1. Alpha-2 adrenergic activity of bromocriptine and quinpirole in chicken pineal gland. Effects on melatonin synthesis and [3H]rauwolscine binding.
      J Zawilska and P M Iuvone
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1047-1052;

  3. Zeman, S

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;

  4. Zimmerman, D M

    1. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
      D D Schoepp, P L Ornstein, J D Leander, D Lodge, C R Salhoff, S Zeman and D M Zimmerman
      Journal of Pharmacology and Experimental Therapeutics December 1990, 255 (3) 1301-1308;
Back to top

In this issue

Advertisement